BALL KRISTINE M
Reporting owner on Forms 3, 4 and 5, CIK 1266163.
BALL KRISTINE M reported on 2 issuers in 3 filings, the latest a Form 4 filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.CIK 907654 | director | 1 | 2026-11-13 |
| Enliven Therapeutics, Inc. CIK 1672619 | director | 1 | 2026-10-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | M exercised | +18,000 | $6.84 | 18,000 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -1,196 | $102.0967 | 16,804 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -1,300 | $103.0932 | 15,504 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -2,039 | $104.1622 | 13,465 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -10,765 | $105.3141 | 2,700 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -2,500 | $106.052 | 200 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Common Stock | 2026-11-12 | S sold | -200 | $106.985 | 0 | Form 4 |
| ORKA · Oruka Therapeutics, Inc.Stock Option (Right to Buy), derivative | 2026-11-12 | M exercised | -18,000 | $0 | 53,426 | Form 4 |
| ELVN · Enliven Therapeutics, Inc.Stock Option (right to buy), derivative | 2026-10-14 | A granted | +23,394 | $0 | 23,394 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000907654-26-000115 | Oruka Therapeutics, Inc. | 2026-11-13 | ||
| Form 4 0001266163-26-000003 | Enliven Therapeutics, Inc. | 2026-10-16 | ||
| Form 3 0001266163-26-000002 | Enliven Therapeutics, Inc. | 2026-10-16 |